Randomized Comparison of Every-2-Week Darbepoetin Alfa and Weekly Epoetin Alfa for the Treatment of Chemotherapy-Induced Anemia: The 20030125 Study Group TrialJohn A. Glaspy, Greg Rossi, Ralph V. Boccia et al.|Journal of Clinical Oncology|2006Cited by 78
An Evaluation of the Effectiveness of Darbepoetin alfa 300 mcg Every 3 Weeks (Q3W) on Clinical Outcomesin Cancer Patients with Chemotherapy-Induced Anemia.Ralph V. Boccia, G. A. Otterson, Delong Liu et al.|Blood|2004Cited by 2
Effectiveness of Darbepoetin alfa Administered Every 3 Weeks on Clinical Outcomes in Patients with Hematologic Malignancies and Chemotherapy-Induced Anemia.Ralph V. Boccia, G. A. Otterson, Greg Rossi et al.|Blood|2005Cited by 1